The former Colorado State guard has struggled to establish a set role with the Tar Heels, as he has deal with uneven ...
The Tar Heels strengthened their frontcourt this offseason, landing the former Arizona center through the transfer portal.
MedPage Today on MSN
Bispecific Trial in Myeloma Sparks Talks of 'Functional Cure'
Combination reduced risk of progression or death by 83% compared to standard triplet ...
With the addition of Nano Banana Pro, Filmora’s AI Image gains higher fidelity and more precise control. Built on the Gemini ...
Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular ...
The addition of epcoritamab to standard therapy significantly improved PFS for patients with relapsed or refractory ...
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...
Aris Mining is positioned for multi-year profitable growth, targeting 1 Mozpa production by 2031—over 4x its current ...
HRE surged on fresh scandium and yttrium hits at Radium Hill, while newly listed BMC impressed with a strong first ... Read ...
ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback